Several studies have emerged using radiomics as a “virtual biopsy” for EGFR mutation status in lung cancer patients, showing moderate performance in the prediction of EGFR mutation status with AUC values ranging between 0.75 and 0.9595–97 (Table 3). The gene discussed is EGFR; the disease is lung cancer.